| Raptiva (Efalizumab) Drug Information: Description, User Reviews ... Learn about the prescription medication Raptiva (Efalizumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Read More |
| Efalizumab - Wikipedia, the free encyclopedia Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. Read More |
| Raptiva is withdrawn from the U.S. market - UPI.com WASHINGTON, April 9 (UPI) -- The U.S. Food and Drug Administration says Genentech Inc. is withdrawing the psoriasis drug Raptiva and it will no longer be available in ... Read More |
| Raptiva Information from Drugs.com Raptiva (efalizumab) is used to treat plaque psoriasis (raised, silvery flaking of the skin) in adults. Includes Raptiva side effects, interactions and indications. Read More |
| Raptiva side effects lead to serious medical problems, Raptiva ... Raptiva side effects lead to serious medical problems, Raptiva law suit, Raptive side effects, Raptiva case Read More |
| Raptiva Side Effects PML Recall Lawsuits - Raptiva Recall Lawsuit ... Raptiva Lawsuits - Serious and rare brain infections reported by FDA due to Raptiva users. Talk to lawyer about Nationwide Raptiva Lawsuits and possible Raptiva ... Read More |
| Raptiva® PML | RaptivaPML.com We're investigating cases of the psoriasis medication, Raptiva, where patients have developed progressive multifocal leukoencephalopathy (PML). Learn more. Read More |
| Raptiva (efalizumab) medical facts from Drugs.com Physician reviewed Raptiva patient information - includes Raptiva description, dosage and directions. Read More |
| FDA Orders "Black Box" Warning for Psoriasis Drug Raptiva The FDA has ordered a ... (Editor's note: On April 8, 2009, Genentech announced it was voluntarily pulling Raptiva from the market.) Read More |
| Raptiva Side Effects Lawsuits | Side Effects: Serious Infections ... Raptiva Side Effects Lawsuits | Serious infections and malignancies reported in patients taking Rapitva include malignant melanoma and non-melanoma skin cancer, non ... Read More |
